Last ¥6,020 JPY
Change Today +40.00 / 0.67%
Volume 157.8K
4555 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
Frankfurt
As of 2:00 AM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

sawai pharmaceutical co ltd (4555) Snapshot

Open
¥5,990
Previous Close
¥5,980
Day High
¥6,040
Day Low
¥5,970
52 Week High
11/13/13 - ¥7,540
52 Week Low
02/6/14 - ¥5,600
Market Cap
229.5B
Average Volume 10 Days
143.5K
EPS TTM
¥350.36
Shares Outstanding
38.1M
EX-Date
09/26/14
P/E TM
17.2x
Dividend
¥100.00
Dividend Yield
1.58%
Current Stock Chart for SAWAI PHARMACEUTICAL CO LTD (4555)

Related News

No related news articles were found.

sawai pharmaceutical co ltd (4555) Related Businessweek News

No Related Businessweek News Found

sawai pharmaceutical co ltd (4555) Details

Sawai Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells, imports, and exports pharmaceutical products in Japan. The company offers prescription drugs in various formulations, such as tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc. The company also provides antihyperlipidemic agents, diabetes drugs, and OTC drugs. It serves dispensing pharmacies, clinics, DPC hospitals, hospitals, and others. The company was founded in 1929 and is headquartered in Osaka, Japan.

1,121 Employees
Last Reported Date: 06/25/14
Founded in 1929

sawai pharmaceutical co ltd (4555) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sawai pharmaceutical co ltd (4555) Key Developments

Sawai Pharmaceutical Co. Ltd., Q1 2015 Earnings Call, Aug 07, 2014

Sawai Pharmaceutical Co. Ltd., Q1 2015 Earnings Call, Aug 07, 2014

Sawai Pharmaceutical Co. Ltd. Announces Earnings Results for the First Quarter Ended June 30, 2014; Provides Earnings Guidance for the Second Quarter and Full Year of 2014

Sawai Pharmaceutical Co. Ltd. announced earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales were ¥25,124 million against ¥21,906 million a year ago. Operating income was ¥5,025 million against ¥5,831 million a year ago. Ordinary income was ¥5,029 million against ¥5,873 million a year ago. Net income was ¥3,438 million or ¥93.48 per diluted share against ¥3,770 million or ¥101.95 per diluted share a year ago. The company provided earnings guidance for the second quarter of September 2014. For the quarter, the company expects net sales of ¥50,500 million, operating income of ¥10,100 million, ordinary income of ¥10,100 million and net income of ¥6,500 million and 176.89 income per share. For the full year, the company expects net sales of ¥106,000 million, operating income of ¥21,000 million, ordinary income of ¥20,900 million, and net income of ¥13,500 million and 367.38 income per share.

Sawai Pharmaceutical Co. Ltd. Presents at Bank of America Merrill Lynch Japan Conference 2014, Sep-08-2014

Sawai Pharmaceutical Co. Ltd. Presents at Bank of America Merrill Lynch Japan Conference 2014, Sep-08-2014 . Venue: Grand Hyatt Tokyo, Tokyo, Japan. Speakers: Mitsuo Sawai, President and Representative Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4555:JP ¥6,020.00 JPY +40.00

4555 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Sanofi €88.25 EUR +0.72
View Industry Companies
 

Industry Analysis

4555

Industry Average

Valuation 4555 Industry Range
Price/Earnings 17.5x
Price/Sales 2.2x
Price/Book 2.0x
Price/Cash Flow 17.3x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAWAI PHARMACEUTICAL CO LTD, please visit www.sawai.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.